Samrat Pharmachem share news and announcements
BSE: 530125Pharmaceuticals & BiotechnologySmall Cap
Last close ₹277.50down ₹10.60 (3.68%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹288.10.
52-week range of traded prices to 23 Oct 2026
₹190.00Low, 30 Mar 2026₹309.85High, 30 Oct 2025
- Next results date: the board meets on 14 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹86 Cr3,210th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.16
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,601
Samrat Pharmachem disputes and clarifications
24 filed, newest first.
Apr 2023
13 Apr · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on April 12, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Dec 2021
27 Dec · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on December 27, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2021
27 Apr · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on April 27, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Dec 2020
7 Dec · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on December 7, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Aug 2020
27 Aug · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on August 27, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jul 2020
9 Jul · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on July 9, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2020
15 Apr · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on April 15th, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Oct 2019
30 Oct · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on 30th October, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2019
4 Apr · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on April 04, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jan 2019
21 Jan · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on January 21, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....9 Jan · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on January 09, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2018
22 Nov · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd on November 22, 2018 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Mar 2015
18 Mar · Legal
With reference to the Increase in Price, Samrat Pharmachem Ltd has Clarified to BSE that : "In this connection, we would like to inform you that Company has not made any big announcement ....18 Mar · Legal
Exchange has sought clarification from Samrat Pharmachem Ltd with reference to increase in price on March 18, 2015. The reply is awaited.
Jul 2014
18 Jul · Legal
With reference to the Increase in Price, Samrat Pharmachem Ltd has Clarified to BSE as under: "The Company has not made any big announcement having impact on its operation and performance ....